Summary:
Summary Statement of Deficiencies D0000 An initial Clinical Laboratory Improvement Amendments (CLIA) survey was completed on February 27, 2023. The laboratory was not in compliance with all applicable CLIA requirements found at 42 CFR 493.1 through 42 CFR 493.1780. The following deficiencies were cited: D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on lack of testing personnel peer review documents and lab director interview, the laboratory failed to verify at least twice annually the accuracy of Potassium Hydroxide (KOH) testing performed. Findings: 1. The lack of testing personnel documents revealed twice annual peer reviews were not performed for KOH testing in 2021, 2022, and 2023 thus far. 2. Interview with the laboratory director in the lab on 2 /27/2023 at 1:59 PM, confirmed the finding. D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on Procedure manual (SOP) review and interview with the lab director (LD), Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- the laboratory failed to have an approved written procedure for Potassium Hydroxide (KOH). Findings: 1. SOP review revealed the laboratory did not a written procedure for KOH. 2. Interview with the LD in the lab on 2/27/2023 at 1:59 PM confirmed the lack of the aforementioned procedure. D5451 CONTROL PROCEDURES CFR(s): 493.1256(d)(3)(iii)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- At least once a day patient specimens are assayed or examined perform the following for-- Test procedures producing graded or titered results include a negative control material and a control material with graded or titered reactivity, respectively; 493.1256 (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on quality control (QC) document review and lab director interview, the laboratory failed to perform and document QC on potassium hydroxide (KOH) slides. Findings: 1. No QC documents were available to review on KOH slides at the time of survey. 2. Interview with the lab director on 02/27/2023 at 1:39 PM in the lab, confirmed controls were not performed on KOH slides . D6029 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(11) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(11) Ensure that prior to testing patients' specimens, all personnel have the appropriate education and experience, receive the appropriate training for the type and complexity of the services offered, and have demonstrated that they can perform all testing operations reliably to provide and report accurate results. This STANDARD is not met as evidenced by: Based on training and competency document review and interview with the lab director, the lab director failed to ensure the testing personnel receive the appropriate training and competency for potassium hydroxide (KOH) testing performed. Findings: 1. No KOH training documents were available for the years 2021, 2022, or 2023 to date. 2. No KOH competency documents were available for the years 2021, 2022, or 2023 to date. 3. Interview with the lab director in the lab on 02/27/2023 at 1:59 PM confirmed the findings. -- 2 of 2 --